An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine. Issue 37 (8th September 2015)

• Record Type: Journal Article
• Authors: Lee, Bruce Y.; Bartsch, Sarah M.; Mvundura, Mercy; Jarrahian, Courtney; Zapf, Kristina M.; Marinan, Kathleen; Wateska, Angela R.; Snyder, Bill; Swaminathan, Savitha; Jacoby, Erica; Norman, James J.; Prausnitz, Mark R.; Zehrung, Darin
• Is Part Of: Vaccine. Volume 33:Issue 37(2015)
• Page Start: 4727
• Page End: 4736
• Publication Date: 2015-09-08
• Subjects: Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2015.02.076
• Languages: English
• ISSNs: 0264-410X

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Microneedle patches (MNPs) may bring potential advantages over existing vaccine technologies.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">We evaluated their potential economic and epidemiologic impacts in various vaccination settings.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Administered by healthcare providers, MNPs would be cost-effective under most conditions tested.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">Self-administration may have a reduced administration success and fewer effective vaccinations.</p> </list-item> <list-item id="lsti0025"> <label></label> <p id="par0025">Efficacy or compliance increases could offset reduced self-administration success.</p> </list-item> </list> </p> </sec> </abstract>